Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity

Abstract A large proportion of patients with multiple sclerosis (MS) have spasticity, which has a marked impact on their quality of life. Anecdotal evidence suggests

September 19, 2019

Symptom Management and Quality of Life of Palliative Cancer Patients After Being Administered with Thai Medicinal Cannabis

Abstract This cross-sectional aimed to; 1) to explore the symptom management and quality of life (QoL) of palliative cancer patients, 2) to compare the perceived

October 3, 2024

Survival rate of patients with combined hepatocellular cholangiocarcinoma receiving medical cannabis treatment: A retrospective, cohort comparative study

Abstract Background Cholangiocarcinoma (CCA) incidence in Northeastern Thailand is very high and a major cause of mortality. CCA patients typically have a poor prognosis and

February 15, 2026

Survey Results of Pain Treatments in Adults with Cerebral Palsy

Objectives—To identify the types and frequencies of pain treatments used by individuals with cerebral palsy (CP); examine the perceived effectiveness of these treatments; and identify

September 19, 2019

Survey on Cannabis Use in Parkinson’s Disease: Subjective Improvement of Motor Symptoms

An anonymous questionnaire sent to all patients attending the Prague Movement Disorder Centre revealed that 25% of 339 respondents had taken cannabis and 45.9% of

Survey of Patients Employing Cannabigerol-Predominant Cannabis Preparations: Perceived Medical Effects, Adverse Events, and Withdrawal Symptoms

Please use this link to access this publication. Abstract Introduction: Cannabigerol (CBG), and its precursor before decarboxylation, cannabigerolic acid is sometimes labeled the “mother of all

February 29, 2024

Suppression of T cell costimulator ICOS by Delta9-tetrahydrocannabinol

Abstract   Inducible costimulator (ICOS), a prototypic T cell costimulator, is induced on activated T cells. ICOS regulates T cell activation and Th cell differentiation

May 17, 2021

Suppression of human macrophage interleukin-6 by a nonpsychoactive cannabinoid acid

Interleukin-6 (IL-6) is a multifunctional cytokine which contributes to inXammation and tissue injury in several diseases. Thus, inhibition of IL-6 production may be a useful

September 19, 2019

Supporting gut health with medicinal cannabis in people with advanced cancer: potential benefits and challenges

Abstract The side effects of cancer therapy continue to cause significant health and cost burden to the patient, their friends and family, and governments. A

November 29, 2023

Supporting gut health with medicinal cannabis in people with advanced cancer: potential benefits and challenges

Please use this link to access this publication: https://www.nature.com/articles/s41416-023-02466-w Abstract The side effects of cancer therapy continue to cause significant health and cost burden to the

December 6, 2023